Home
Conditions
Infections, Meningococcal

Clinical trial condition

Infections, Meningococcal

Explore clinical trials studying Infections, Meningococcal. Study availability and eligibility vary by location and protocol.

65 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Infections, Meningococcal trial results

Completed

N. Meningitidis Carriage Study

NCT01808365

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Manila, Philippines

View Trial Details

Completed

Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects

NCT01641042

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Antioch, California, United States

GSK Investigational Site Daly City, California, United States

GSK Investigational Site Fremont, California, United States

GSK Investigational Site Hayward, California, United States

View all 16 locations

View Trial Details

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age

NCT01767376

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +14 more
Locations: GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

GSK Investigational Site Tuttlingen, Baden-Wurttemberg, Germany

GSK Investigational Site Bindlach, Bavaria, Germany

View all 15 locations

View Trial Details

Completed

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612

NCT00974363

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Goā, India

GSK Investigational Site Indore, India

GSK Investigational Site New Delhi, India

GSK Investigational Site Pune, India

View Trial Details

Completed

Study in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612

NCT00390143

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Aarhus N, Denmark

View Trial Details

Completed

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

NCT00126984

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Guessing, Austria

GSK Investigational Site Neufeld/Leitha, Austria

GSK Investigational Site Salzburg, Austria

GSK Investigational Site Villach, Austria

View all 42 locations

View Trial Details

Completed

Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

NCT00126945

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Aarhus N, Denmark

View Trial Details

Completed

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

NCT00196963

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Thuin, Belgium

View Trial Details

Completed

Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs

NCT00227422

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Beirut, Lebanon

View Trial Details

Completed

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers

NCT00135564

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: Not specified

View Trial Details

Infections, Meningococcal

Infections, Meningococcal trial results

Related conditions